Ocugen Inc Stock Buy Hold or Sell Recommendation
| OCGN Stock | USD 1.59 0.12 7.02% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Ocugen Inc is 'Cautious Hold'. Macroaxis provides Ocugen buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Ocugen positions. The advice algorithm takes into account all of Ocugen's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Ocugen's buy or sell advice are summarized below:
Real Value 2.2 | Target Price 4 | Hype Value 1.43 | Market Value 1.59 | Naive Value 1.57 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Ocugen Inc given historical horizon and risk tolerance towards Ocugen. When Macroaxis issues a 'buy' or 'sell' recommendation for Ocugen Inc, the advice is generated through an automated system that utilizes algorithms and statistical models.
Ocugen |
Execute Ocugen Buy or Sell Advice
The Ocugen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Ocugen Inc. Macroaxis does not own or have any residual interests in Ocugen Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Ocugen's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Solid | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Ocugen Trading Alerts and Improvement Suggestions
| Ocugen Inc is way too risky over 90 days horizon | |
| Ocugen Inc may become a speculative penny stock | |
| Ocugen Inc appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (75.52 M) with loss before overhead, payroll, taxes, and interest of (49.76 M). | |
| Ocugen Inc currently holds about 101.6 M in cash with (67.67 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.46. | |
| Ocugen Inc has a frail financial position based on the latest SEC disclosures | |
| Latest headline from businesswire.com: INVESTOR ALERT Law Offices of Howard G. Smith Announces Investigation of Ocugen, Inc. on Behalf of Investors |
Ocugen Returns Distribution Density
The distribution of Ocugen's historical returns is an attempt to chart the uncertainty of Ocugen's future price movements. The chart of the probability distribution of Ocugen daily returns describes the distribution of returns around its average expected value. We use Ocugen Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Ocugen returns is essential to provide solid investment advice for Ocugen.
| Mean Return | 1.82 | Value At Risk | -9.04 | Potential Upside | 16.67 | Standard Deviation | 8.49 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Ocugen historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Ocugen Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Ocugen is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Ocugen Inc backward and forwards among themselves. Ocugen's institutional investor refers to the entity that pools money to purchase Ocugen's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 296.2 K | Cubist Systematic Strategies, Llc | 2023-12-31 | 265.5 K | Renaissance Technologies Corp | 2023-12-31 | 246.2 K | T. Rowe Price Associates, Inc. | 2023-12-31 | 187.1 K | Jpmorgan Chase & Co | 2023-12-31 | 182.8 K | Charles Schwab Investment Management Inc | 2023-12-31 | 170.3 K | Two Sigma Investments Llc | 2023-12-31 | 157.3 K | Bank Of America Corp | 2023-12-31 | 155.2 K | D. E. Shaw & Co Lp | 2023-09-30 | 139 K | Vanguard Group Inc | 2023-12-31 | 12 M | Blackrock Inc | 2023-12-31 | 3.7 M |
Ocugen Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 5.8M | 16.6M | 70.9M | (17.5M) | (48.1M) | (45.7M) | |
| Free Cash Flow | (16.9M) | (15.0M) | (48.9M) | (64.5M) | (77.4M) | (73.6M) | |
| Depreciation | 60.6K | 102.1K | 229K | 480K | 698K | 584.7K | |
| Other Non Cash Items | 2.3M | 7.6M | 799K | 1.1M | 2.2M | 3.1M | |
| Capital Expenditures | 29.4K | 306.8K | 939K | 4.5M | 9.8M | 10.3M | |
| Net Income | (20.2M) | (21.8M) | (58.4M) | (81.4M) | (75.5M) | (71.7M) | |
| End Period Cash Flow | 7.6M | 24.2M | 95.1M | 77.6M | 53.5M | 39.0M | |
| Net Borrowings | 5.3M | (4.7M) | (10K) | 500K | 450K | 676.9K | |
| Change To Netincome | 5.8M | 8.2M | 7.7M | 11.6M | 13.3M | 14.0M | |
| Investments | (2.3M) | (306.8K) | (1.8M) | (17.0M) | (9.5M) | (9.0M) |
Ocugen Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Ocugen or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Ocugen's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Ocugen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | 1.63 | |
β | Beta against NYSE Composite | 2.56 | |
σ | Overall volatility | 8.47 | |
Ir | Information ratio | 0.20 |
Ocugen Volatility Alert
Ocugen Inc is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Ocugen's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Ocugen's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Ocugen Fundamentals Vs Peers
Comparing Ocugen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Ocugen's direct or indirect competition across all of the common fundamentals between Ocugen and the related equities. This way, we can detect undervalued stocks with similar characteristics as Ocugen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Ocugen's fundamental indicators could also be used in its relative valuation, which is a method of valuing Ocugen by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Ocugen to competition |
| Fundamentals | Ocugen | Peer Average |
| Return On Equity | -0.98 | -0.31 |
| Return On Asset | -0.53 | -0.14 |
| Current Valuation | 391.79 M | 16.62 B |
| Shares Outstanding | 256.6 M | 571.82 M |
| Shares Owned By Insiders | 1.45 % | 10.09 % |
| Shares Owned By Institutions | 10.33 % | 39.21 % |
| Number Of Shares Shorted | 43.48 M | 4.71 M |
| Price To Earning | (1.81) X | 28.72 X |
| Price To Book | 7.51 X | 9.51 X |
| Price To Sales | 25,069 X | 11.42 X |
| Gross Profit | (49.76 M) | 27.38 B |
| EBITDA | (80.36 M) | 3.9 B |
| Net Income | (75.52 M) | 570.98 M |
| Cash And Equivalents | 101.6 M | 2.7 B |
| Cash Per Share | 0.46 X | 5.01 X |
| Total Debt | 6.37 M | 5.32 B |
| Debt To Equity | 0.07 % | 48.70 % |
| Current Ratio | 7.21 X | 2.16 X |
| Book Value Per Share | 0.23 X | 1.93 K |
| Cash Flow From Operations | (67.67 M) | 971.22 M |
| Short Ratio | 4.05 X | 4.00 X |
| Earnings Per Share | (0.32) X | 3.12 X |
| Target Price | 5.33 | |
| Number Of Employees | 84 | 18.84 K |
| Beta | 3.74 | -0.15 |
| Market Capitalization | 438.79 M | 19.03 B |
| Total Asset | 108.63 M | 29.47 B |
| Retained Earnings | (213.02 M) | 9.33 B |
| Working Capital | 80.03 M | 1.48 B |
| Current Asset | 17.53 M | 9.34 B |
| Current Liabilities | 4.21 M | 7.9 B |
| Net Asset | 108.63 M |
Note: Payment of 41633 shares by Arun Upadhyay of Ocugen subject to Rule 16b-3 [view details]
Ocugen Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Ocugen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Ocugen Buy or Sell Advice
When is the right time to buy or sell Ocugen Inc? Buying financial instruments such as Ocugen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 293K | 9.9M | 11.4M | 12.0M | Total Assets | 105.8M | 108.6M | 124.9M | 131.2M |
Use Investing Ideas to Build Portfolios
In addition to having Ocugen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run SRI Sustainable Growth Thematic Idea Now
SRI Sustainable Growth
Socially responsible investments that include companies making a positive, sustainable or social impact and exclude those making a negative impact. The SRI Sustainable Growth theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize SRI Sustainable Growth Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Ocugen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Ocugen Inc information on this page should be used as a complementary analysis to other Ocugen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Ocugen Stock analysis
When running Ocugen's price analysis, check to measure Ocugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ocugen is operating at the current time. Most of Ocugen's value examination focuses on studying past and present price action to predict the probability of Ocugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ocugen's price. Additionally, you may evaluate how the addition of Ocugen to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
Is Ocugen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.32) | Return On Assets (0.53) | Return On Equity (0.98) |
The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.